Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: a case control study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: a case control study ; volume:1 ; number:1 ; day:13 ; month:12 ; year:2001 ; pages:1-10 ; date:12.2001
BMC gastroenterology ; 1, Heft 1 (13.12.2001), 1-10, 12.2001
- Creator
-
Bekkering, Frank C.
- Contributor
-
Neumann, Avidan U.
Brouwer, Johannes T.
Levi-Drummer, Rachel S.
Schalm, Solko W.
SpringerLink (Online service)
- DOI
-
10.1186/1471-230X-1-14
- URN
-
urn:nbn:de:1111-20160715245
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bekkering, Frank C.
- Neumann, Avidan U.
- Brouwer, Johannes T.
- Levi-Drummer, Rachel S.
- Schalm, Solko W.
- SpringerLink (Online service)
Other Objects (12)
Viral recognition and the antiviral interferon response
Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses
Viral recognition and the antiviral interferon response
Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses
Viral recognition and the antiviral interferon response
Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies